Erlotinib Completed Phase N/A Trials for Lung Cancer Non-Small Cell Cancer (NSCLC) Health Services Research

IndicationsStatusPurposePhase
CompletedHealth Services ResearchNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00883480Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced Adenocarcinoma